BEONE MEDICINES LTD. (ONC) /

The cash flow of BEONE MEDICINES LTD. over the past 10 years

Chart BEONE MEDICINES LTD.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →

In fiscal 2025, the latest fiscal year on file, BEONE MEDICINES LTD.'s operating cash flow was $1.13B and its capital expenditures $185.84M, leaving free cash flow of $941.74M. Free cash flow was above zero in 1 of the 10 years shown. It ranged from -$1.82B in fiscal 2022 to $941.74M in fiscal 2025. Capital expenditures were highest in fiscal 2023, at $561.9M.

Year by year

Fiscal yearOperating cash flowCapital expendituresFree cash flow*
2025ended Dec 31, 2025$1.13B$185.84M$941.74M
2024ended Dec 31, 2024-$140.63M$492.66M-$633.29M
2023ended Dec 31, 2023-$1.16B$561.9M-$1.72B
2022ended Dec 31, 2022-$1.5B$325.43M-$1.82B
2021ended Dec 31, 2021-$1.3B$262.94M-$1.56B
2020ended Dec 31, 2020-$1.28B$117.51M-$1.4B
2019ended Dec 31, 2019-$750.27M$89.61M-$839.88M
2018ended Dec 31, 2018-$547.72M$70.28M-$618M
2017ended Dec 31, 2017$12.75M$46.37M-$33.62M
2016ended Dec 31, 2016-$89.51M$23.5M-$113.02M

Fiscal years as BEONE MEDICINES LTD. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on BEONE MEDICINES LTD.

Companies of a similar size

Not investment advice. This page shows what BEONE MEDICINES LTD. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.